Case 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page 1of9 Page ID #:14612
JONATHAN A. SHAPIRO (257199) JOEL FLEMING (281264)
WILMER CUTLER PICKERING HALE AND DORR LLP
950 Page Mill Road
Palo Alto, CA 94304
Tel (220) 858-6101
Fax: (650) 858-6100 jonathan.shapiro @ wilmerhale.com
ANDREA J. ROBINSON (PRO HAC VICE)
TIMOTHY J. PERLA (PRO HAC VICE)
WILMER CUTLER PICKERING HALE
AND DORR LLP
60 State Street
Boston, MA 02109
Tel: e173 526-6000
Fax: (617) 526-5000
10 | andrea.robinson @wilmerhale.com timothy.perla@ wilmerhale.com
11 | Attorneys for Defendant Life Insurance
Company of the Southwest
Oo wonnrnANn nan ua ff WO NO
12 13 14 UNITED STATES DISTRICT COURT 15 CENTRAL DISTRICT OF CALIFORNIA 16 SOUTHERN DIVISION
JOYCE WALKER, KIM BRUCE CLASS ACTION 17 |HOWLETT, and MURIEL SPOONER, on) —. —<CS™S
behalf of themselves and all others CASE NO.: CV 10-9198 JVS (RNBx) 18 | similarly situated,
Formerly Case No.: 3:10-cv -04852 JS 19 Plaintiffs, from Northern District of California 20 VS. APPLICATION TO SEAL
21 | LIFE INSURANCE COMPANY OF THE | PLAINTIFFS’ MOTION FOR CLAS SOUTHWEST, a Texas corporation, and CERTIFICATION AND CERTAIN
22 | DOES 1-50 DOCUMENTS AND EXHIBITS
SUBMITTED IN SUPPORT THEREOF
23 Defendant.
Judge: Hon. James V. Selna 24 Courtroom: 10C
Date: September 18, 2012 25 Time: 1:30 p.m. 26 27
28
8118087v1 9/11/2012 6:39 PM
ActiveUS 100916059v.1
0 ONY A HN BR WOW NY KO
NO NO NBO WN NO NHN HN NHN KN HH HF KF PF Fr RP OF OU Sh oe on DWN nN BW NY KF DO UO WAI Da fF WW NYO KF CO
8118087v1 9/11/2012 6:39 PM
se 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page2of9 Page ID PLEASE TAKE NOTICE THAT pursuant to the Court’s emailed request of September 11, 2012, Civil Local Rule 79-5.1 and the Court’s Second Amended Protective Order in this action, Dkt. 103 at { 10 (Sept. 27, 2011), Defendant Life Insurance Company of the Southwest (“LSW?”’) submits this application to the Court for an Order sealing (1) Plaintiffs’ Motion for Class Certification; (2) exhibits C, E, F, I, S, and U to the Declaration of Brian P. Brosnahan; (3) the Declaration of Dr. Patrick L. Brockett and exhibits G, H, L, N, Q, and S thereto; and (4) the Declaration of Lesa Dinglasan and exhibits C, D, E, F, and H thereto. Under Civil Local Rule 79-5.1, a party can request that documents be filed under seal by submitting a written application along with the documents sought to be filed under seal. The Court’s Second Amended Protective Order (the “Protective Order’’) requires that an application to seal be filed whenever any papers are filed containing information and/or documents designated as “CONFIDENTIAL” or “CONFIDENTIAL INFORMATION — PROTECTIVE ORDER.” Dkt. 103 at {10. I. LSW’s Application LSW applies to seal the above-listed materials on the grounds that they contain confidential information protected by the Protective Order. The Court previously granted LSW’s application to seal certain of these materials when submitted with the parties’ Joint Stipulation on Plaintiffs’ Motion to Compel and Plaintiffs’ motion for review of Magistrate Judge Block’s order pertaining thereto and supporting papers. See Civil Minutes, Dkt. 136; Dkt. 197; Dkt. 209. The specific grounds that apply to each document are set forth below: Plaintiffs’ Motion for Class Certification (i) Plaintiffs’ Motion for Class Certification refers to and/or directly quotes confidential information from the sealed exhibits listed below. To the extent it does so, those references should be sealed as well.
Certain Exhibits to the Declaration of Brian P. Brosnahan
ActiveUS 100916059v.1
0 oN A HN BR WOW NH KO
NO wNO NO WN NO NHN HN NHN KN HH HF HF PF FF Pr OF OU Sh eR on DWN nN BPW NY KF OD UO WAI HD na fF WwW NY KF CO
8118087v1 9/11/2012 6:39 PM
se 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page 3of9 PageID (i) Brosnahan Dec., Ex. C isa eae fot LSW to Plaintiffs, which contains information about LSW’s internal processes with respect to life insurance policies, which are proprietary. This letter was drafted by LSW for Plaintiffs pursuant to a negotiated agreement which contemplated confidential treatment of the information provided. If released, this information would likely be sufficient to allow a competitor understand how LSW designs, constructs, and implements its life policies. Thus, this document further reflects confidential financial information about the value of Plaintiffs’ LSW policies. The information contained in the letter is confidential, non-public commercial information that, if disclosed to the general public or competitors of LSW could reasonably and in good faith be expected to result in prejudice or harm. For this reason, it was designated as CONFIDENTIAL.
(ii) |Brosnahan Dec., Ex. E is an internal LSW document containing discussions of LSW’s business strategies and internal compliance policies. The face of the document states “For Agent Use Only—Not For Use With The Public.” And with good reason: this document contains, among other things, confidential communications between LSW and its agents about marketing policies, replacement of policies, and procedures for addressing customer complaints. This is confidential, non-public commercial information about LSW that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated CONFIDENTIAL.
(iii) Brosnahan Dec., Ex. F is a non-party’s LSW Illustration, which contains confidential information about an individual, including age, underwriting class and policy value. This is confidential, non-public personal identifying information that, if disclosed could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated CONFIDENTIAL.
(iv) Brosnahan Dec., Ex. I is an internal LSW email chain discussing marketing strategies and compliance policies, as well as strategies regarding positioning vis-
a-vis LSW’s competitors. Specifically, it discusses marketing strategies for a 2
ActiveUS 100916059v.1
0 oN A NH BW NY KO
NO wNO NP WN NO NHN HN HN KN HH HF KF PF FF Pr OF OR Ph oe oN DWN nr BW NY KF OD UO WAI Da fF WW NY KF CO
8118087v1 9/11/2012 6:39 PM
se 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page 4of9 PageID particular category of consumers (doctor. This is confidential, non-public commercial information about LSW products that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated CONFIDENTIAL. (v) Brosnahan Dec., Ex. S contains excerpts from the deposition of Elizabeth MacGowan. In the testimony excerpted therein, Ms. MacGowan testified to, among other things, LSW’s strategy regarding confidential actuarial calculations. Ms. MacGowan also testified about a document discussing LSW’s strategies regarding the pricing of various aspects of its products and the margin that it receives on those products. This is confidential, non-public commercial information that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm.
(vi) Brosnahan Dec., Ex. U contains excerpts from the deposition of Michael Richardson. In the testimony excerpted herein, Mr. Richardson testified to, among other things, the internal workings of LSW’s proprietary computer software, including certain strategic choices made by LSW in determining the content of illustrations generated by the ICS software program. This is confidential, non- public commercial information that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, this testimony was designated CONFIDENTIAL.
Declaration of Dr. Patrick Lee Brockett and Certain Exhibits Thereto
(i) | The Declaration of Dr. Patrick Lee Brockett refers to and/or directly quotes confidential information from the exhibits listed below.
Gi) Brockett Dec., Ex. Gis an internal LSW document that discusses LSW’s business strategies, including pricing goals and constraints for certain LSW products. This includes sensitive information about LSW’s margins, overhead, and commissions. It includes discussions about LSW’s pricing targets for its return- on-investment, planned rate structures and the algorithm used to determine
minimum premiums. It also includes assumed lapse rates. This is confidential, non- 3
ActiveUS 100916059v.1
0 ON A NW BR WOW NY KO
NO wNO NBO WN HN NHN HN NHN KN HH HF KF PF Fr Pr OF OU RP oe on DWN nN BW NY FP ODO UO WAI Da fF WW NY KF CO
8118087v1 9/11/2012 6:39 PM
se 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page5of9 PageID public commercial information dice LsW products that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated CONFIDENTIAL.
(ii) Brockett Dec., Ex. H is an internal LSW document that contains internal testing data and internal pricing assumptions. It also discusses LSW’s historic distribution of business by risk class and issue age as well as its compensation structure for agents and expenses per policy issued. It includes information about LSW’s average policy size (in dollars). This is confidential, non-public commercial information about LSW and LSW’s products that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated CONFIDENTIAL.
(iv) Brockett Dec., Ex. L is a letter from LSW to Plaintiffs, which contains information about LSW’s internal processes with respect to life insurance policies, which are proprietary. This letter was drafted by LSW for Plaintiffs pursuant to a negotiated agreement which contemplated confidential treatment of the information provided. If released, this information would likely be sufficient to allow a competitor understand how LSW designs, constructs, and implements its life policies. Thus, this document further reflects confidential financial information about the value of Plaintiffs’ LSW policies. The information contained in the letter is confidential, non-public commercial information that, if disclosed to the general public or competitors of LSW could reasonably and in good faith be expected to result in prejudice or harm. For this reason, it was designated as CONFIDENTIAL.
(v) Brockett Dec., Ex. Q contains excerpts from the deposition of Elizabeth MacGowan. In the testimony excerpted therein, Ms. MacGowan testified to, among other things, LSW’s strategy regarding confidential actuarial calculations. Ms. MacGowan also testified about a document discussing LSW’s strategies
regarding the pricing of various aspects of its products. This is confidential, non- 4
ActiveUS 100916059v.1
se 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page6of9 Page ID public commercial information fiat | if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, this testimony was designated Confidential. (vi) Brockett Dec., Ex. S contains excerpts from the deposition of Michael Richardson. In the testimony excerpted herein, Mr. Richardson testified to, among other things, the internal workings of LSW’s proprietary computer software, including certain strategic choices made by LSW in determining the content of
illustrations generated by the ICS software program. This is confidential, non-
0 ON A NW BR WOW NH KO
public commercial information that, if disclosed to the general public or
_ i)
competitors of LSW, could reasonably and in good faith be expected to result in
— —
prejudice or harm. For that reason, this testimony was designated
CONFIDENTIAL. Declaration of Lesa Dinglasan and Certain Exhibits Thereto
17. The Declaration of Lesa Dinglasan refers to and/or directly quotes
a aA BP W WN
confidential information from the exhibits listed below. It also provides
— ON
information gathered from a sample of policyholder files provided by LSW to
— —
Plaintiffs, subject to the Protective Order.
—_ (oe)
18. Dinglasan Dec., Ex. C is an Agent’s Report relating to a non-party. It
= \O
contains confidential information about a non-party’s LSW policy, net worth,
N i)
household income, and contact information. This is personal identifying
N —
information that, if disclosed could reasonably and in good faith be expected to
N Nw
result in prejudice or harm. For that reason, it was designated Confidential.
N ie)
19. Dinglasan Dec., Ex. D is a non-party’s policy application. It contains
~~) aN
confidential personal, contact, financial, and medical information (including family
N N
medical history) about a non-party and that person’s LSW policy. This is
N ON
confidential, non-public personal identifying information that, if disclosed to the
N —
general public or competitors of LSW, could reasonably and in good faith be
N oO
expected to result in prejudice or harm. For that reason, it was designated Confidential.
8118087v1 9/11/2012 6:39 PM 5
ActiveUS 100916059v.1
0 oN A nH BR WOW NY KO
NO wo PO WN NO NHN HN NHN KN HH HF KF PF Fr RP OF OR Ph oe on DWN nr BW NY KF TO UO WAI Dna FW NY KF OO
8118087v1 9/11/2012 6:39 PM
se 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page 7of9 PageID
20. Dinglasan Dec., Ex. Bis B nendpares LSW Illustration. It contains confidential financial information about the age and underwriting class of a non- party and the value of a non-party’s LSW policy. This is confidential, non-public commercial information and personal identifying information that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated Confidential.
21. Dinglasan Dec., Ex. F is a non-party’s LSW Illustration. It contains confidential financial information about the age and underwriting class of a non- party and the value of a non-party’s LSW policy. This is confidential, non-public commercial information and personal identifying information that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, it was designated Confidential.
22. Dinglasan Dec., Ex. H contains excerpts from the deposition of Elizabeth MacGowan. In the testimony excerpted therein, Ms. MacGowan testified to, among other things, LSW’s strategy regarding confidential actuarial calculations. Ms. MacGowan also testified about a document discussing LS W’s strategies regarding the pricing of various aspects of its products. This is confidential, non-public commercial information that, if disclosed to the general public or competitors of LSW, could reasonably and in good faith be expected to result in prejudice or harm. For that reason, this testimony was designated Confidential.
II. Conclusion
For all the foregoing reasons, LSW requests that the Court issue an Order sealing (1) Plaintiffs’ Motion for Class Certification; (2) exhibits C, E, F, I, S, and U to the Declaration of Brian P. Brosnahan; (3) the Declaration of Dr. Patrick L. Brockett and exhibits G, H, L, N, Q, and S thereto; and (4) the Declaration of Lesa Dinglasan and exhibits C, D, E, F, and H thereto.
6
ActiveUS 100916059v.1
Case 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page 8of9 Page ID 4619
Dated: September 11, 2012 Respectfully submitted,
WILMER CUTLER PICKERING HALE AND DORR LLP
By:__/s/ Joel Fleming Joel Fleming
Attorneys for Defendant LIFE INSURANCE COMPANY OF THE SOUTHWEST
Oo won nan a ff WO NO
NO wNoO NO NHN NO NHN HN ND KN HH HF KF PF Fr Pr OF OP oe oN DWN nN BW NY KF ODO UO WAI Duna FW NY KF CO
8118087v1 9/11/2012 6:39 PM 7
ActiveUS 100916059v.1
Case 2:10-cv-09198-JVS -RNB Document 329 Filed 09/11/12 Page9of9 Page ID 4620
Oo wornANnn una ff WO NO
NO wNoO PO NHN NO NHN HN NHN KN HH HF KF KF Fr Pr OF OP Ph oe on DWN nN BW NY KF ODO UO WAI Duna fF WwW NY KF CO
8118087v1 9/11/2012 6:39 PM
PROOF OF SERVICE
I am a resident of the Commonwealth of Massachusetts, over the age of
mane ears, and not a party to the within action. My business address 1s i
Imer Cutler Pickering Hale and Dorr LLP, 60 State Street, Boston, MA 02109. On September 11, 2012 I served the within document(s):
APPLICATION TO SEAL PLAINTIFFS’ MOTION FOR CLASS CERTIFICATION AND CERTAIN DOCUMENTS AND EXHIBITS SUBMITTED IN SUPPORT THEREOF
I placed the document(s) listed above in a sealed envelope with postage thereon fully prepaid, in the United States mail at Boston, MA addressed as set forth below.
I personally caused to be emailed the document(s) listed above to the person(s) at the address(es) set forth below.
I electronically filed the document(s) listed above via the CM/ECF system.
I personally caused to be delivered by Facsimile the document(s) listed above to the person(s) at the facsimile number(s) set forth below.
Brian P. Brosnahan
Charles N. Freiberg
Jacob Foster
KASOWITZ, BENSON, TORRES & FRIEDMAN LLP 101 California Street, Suite 2300
San Francisco, CA 94111
(415) 358-4278
Harvey R. Levine
LEVINE & MILLER
550 West C. Street, Suite 1810 San Diego, CA 92101-8596 (619) 231-8638
/s/ Joel Flemin Joel Fleming
ActiveUS 100916059v.1